51 results
Page 2 of 3
8-K
EX-99.1
m42ma3us9u0qwzr0sbku
10 Mar 22
Stoke Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
7:05am
8-K
EX-99.1
wkyfhj8bpff7ikem7
8 Nov 21
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
7:05am
8-K
EX-99.1
xqikrxr0 d0f
10 Aug 21
Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates
7:05am
8-K
EX-99.1
c9i2xhef1bpgg yd06
10 May 21
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
7:05am
8-K
EX-99.1
eyqszkb zbdan
9 Mar 21
Stoke Therapeutics Reports Full Year 2020 Financial Results and Provides Business Updates
7:30am
8-K
EX-99.1
rnkymv xwp
5 Feb 21
Regulation FD Disclosure
4:27pm
8-K
EX-99.1
ssrdvw0849u y0
11 Jan 21
Results of Operations and Financial Condition
8:01am
8-K
EX-99.1
iawqmj1z 0j2j62q
20 Nov 20
Stoke Therapeutics Announces Pricing of $97.5 Million Public Offering
4:08pm
424B5
3cf9bl
20 Nov 20
Prospectus supplement for primary offering
4:06pm
424B5
btt9v
18 Nov 20
Prospectus supplement for primary offering
4:12pm